These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 448678)

  • 61. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
    Phillips OA; Nelson LA; Knaus EE; Allen TM; Fathi-Afshar R
    Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
    Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
    J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
    Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
    J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 7-Azido-actinomycin D: a photoaffinity probe of the sequence specificity of DNA binding by actinomycin D.
    Rill RL; Marsch GA; Graves DE
    J Biomol Struct Dyn; 1989 Dec; 7(3):591-605. PubMed ID: 2627300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L; Narayanan VL; Paull KD
    J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides.
    Palmer BD; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
    J Med Chem; 1988 Apr; 31(4):707-12. PubMed ID: 3351846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy.
    Wadkins RM; Jares-Erijman EA; Klement R; Rüdiger A; Jovin TM
    J Mol Biol; 1996 Sep; 262(1):53-68. PubMed ID: 8809179
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ring-hydroxylated analogues of lucanthone as antitumor agents.
    Archer S; Miller KJ; Rej R; Periana C; Fricker L
    J Med Chem; 1982 Mar; 25(3):220-7. PubMed ID: 7069701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acridine derivatives. III. Preparation and antitumor activity of the novel acridinyl-substituted uracils.
    Kimura M; Okabayashi I; Kato A
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):697-701. PubMed ID: 2752480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and antitumor activity of tropolone derivatives. 4.
    Yamato M; Hashigaki K; Sakai J; Kawasaki Y; Tsukagoshi S; Tashiro T
    J Med Chem; 1987 Jan; 30(1):117-20. PubMed ID: 3806588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.
    Stevens MF; Hickman JA; Stone R; Gibson NW; Baig GU; Lunt E; Newton CG
    J Med Chem; 1984 Feb; 27(2):196-201. PubMed ID: 6694168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure-activity relationships in antitumor aniline mustards.
    Panthananickal A; Hansch C; Leo A
    J Med Chem; 1978 Jan; 21(1):16-26. PubMed ID: 619146
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias.
    Showalter HD; Angelo MM; Berman EM; Kanter GD; Ortwine DF; Ross-Kesten SG; Sercel AD; Turner WR; Werbel LM; Worth DF
    J Med Chem; 1988 Aug; 31(8):1527-39. PubMed ID: 3397990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 7-Substituted actinomycin D (NSC-3053) analogs as fluorescent DNA-binding and experimental antitumor agents.
    Modest EJ; Sengupta SK
    Cancer Chemother Rep; 1974; 58(1):35-48. PubMed ID: 4812836
    [No Abstract]   [Full Text] [Related]  

  • 75. [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone].
    Boido Canu C; Boido V; Sparatore F
    Boll Chim Farm; 1989 Jun; 128(6):208-11. PubMed ID: 2619988
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.
    van den Broek LA; Lázaro E; Zylicz Z; Fennis PJ; Missler FA; Lelieveld P; Garzotto M; Wagener DJ; Ballesta JP; Ottenheijm HC
    J Med Chem; 1989 Aug; 32(8):2002-15. PubMed ID: 2754719
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 7,8-dihydro-5H-isoindolo[1,2-b] [3]benzazepine-5-ones. Part 2: In vitro effect of derivatives substituted at position 7 on leukemia P 388 cells.
    Fuska J; Fusková A; Proksa B
    Pharmazie; 1982 Jun; 37(6):443-5. PubMed ID: 7122688
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Preparation and antileukemic activity of quinolizidinylalkyl-derivatives of 4-aminoquinoline and 9-aminoacridine].
    Boido Canu C; Boido V; Sparatore F
    Boll Chim Farm; 1989 Jun; 128(6):212-5. PubMed ID: 2619989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme.
    Mauger AB; Burke PJ; Somani HH; Friedlos F; Knox RJ
    J Med Chem; 1994 Oct; 37(21):3452-8. PubMed ID: 7932574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of some substituted pyrimidines as possible anti-cancer agents.
    Ganu UK; Ambaye RY; Bhat ML; Panse TB
    Indian J Cancer; 1981 Sep; 18(3):176-80. PubMed ID: 7309121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.